Parisa Samimi1, Joseph Panza1, Jessica Heft1, Li Wang2, Rony Adam1. 1. From the Department of Obstetrics and Gynecology. 2. Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.
Abstract
OBJECTIVES: Limited data exist regarding the impact of state legislation on opioid-prescribing patterns, particularly in states with the highest opioid-prescribing rates in the nation. Our primary objective was to examine the change in the amount of opioid morphine equivalents (OMEs) prescribed at discharge to patients undergoing female pelvic reconstructive surgery after the implementation of state legislation created in response to the opioid crisis. METHODS: At our institution, state legislation went into effect on July 1, 2018, implementing limitations on OMEs prescribed to patients. This retrospective cohort study examines all adult women undergoing female pelvic reconstructive surgery from January 1, 2018, to December 31, 2018. The study compares prescribing practices 6 months before and 6 months after the state law was enacted. RESULTS: In total, 346 patients met inclusion criteria. The 2 groups had similar demographics. Surgical procedures were well distributed, with 52% of cases occurring in the first 6 months of the calendar year. At the time of discharge, 324 (96.7%) patients received an opioid prescription, with an overall average of 197 OMEs. After the implementation of state legislation on July 1, 2018, the amount of OMEs prescribed at discharge significantly decreased, from a median of 210 mg (interquartile range, 150-225) to 150 mg (interquartile range 135-225; P = 0.02). CONCLUSIONS: State legislation was associated with a significant decrease in prescribed OMEs at the time of discharge in patients undergoing female pelvic reconstructive surgery. These results support ongoing legislative efforts to address the current opioid crisis.
OBJECTIVES: Limited data exist regarding the impact of state legislation on opioid-prescribing patterns, particularly in states with the highest opioid-prescribing rates in the nation. Our primary objective was to examine the change in the amount of opioid morphine equivalents (OMEs) prescribed at discharge to patients undergoing female pelvic reconstructive surgery after the implementation of state legislation created in response to the opioid crisis. METHODS: At our institution, state legislation went into effect on July 1, 2018, implementing limitations on OMEs prescribed to patients. This retrospective cohort study examines all adult women undergoing female pelvic reconstructive surgery from January 1, 2018, to December 31, 2018. The study compares prescribing practices 6 months before and 6 months after the state law was enacted. RESULTS: In total, 346 patients met inclusion criteria. The 2 groups had similar demographics. Surgical procedures were well distributed, with 52% of cases occurring in the first 6 months of the calendar year. At the time of discharge, 324 (96.7%) patients received an opioid prescription, with an overall average of 197 OMEs. After the implementation of state legislation on July 1, 2018, the amount of OMEs prescribed at discharge significantly decreased, from a median of 210 mg (interquartile range, 150-225) to 150 mg (interquartile range 135-225; P = 0.02). CONCLUSIONS: State legislation was associated with a significant decrease in prescribed OMEs at the time of discharge in patients undergoing female pelvic reconstructive surgery. These results support ongoing legislative efforts to address the current opioid crisis.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Deborah Dowell; Elizabeth Arias; Kenneth Kochanek; Robert Anderson; Gery P Guy; Jan L Losby; Grant Baldwin Journal: JAMA Date: 2017-09-19 Impact factor: 56.272
Authors: Cobin D Soelberg; Raeford E Brown; Derick Du Vivier; John E Meyer; Banu K Ramachandran Journal: Anesth Analg Date: 2017-11 Impact factor: 5.108
Authors: Sarah S Osmundson; Leslie A Schornack; Jennifer L Grasch; Lisa C Zuckerwise; Jessica L Young; Michael G Richardson Journal: Obstet Gynecol Date: 2017-07 Impact factor: 7.661
Authors: Paul A Harris; Robert Taylor; Brenda L Minor; Veida Elliott; Michelle Fernandez; Lindsay O'Neal; Laura McLeod; Giovanni Delacqua; Francesco Delacqua; Jacqueline Kirby; Stephany N Duda Journal: J Biomed Inform Date: 2019-05-09 Impact factor: 6.317
Authors: Joe Habbouche; Jay Lee; Rena Steiger; James M Dupree; Caitlin Khalsa; Michael Englesbe; Chad Brummett; Jennifer Waljee Journal: JAMA Surg Date: 2018-12-01 Impact factor: 14.766
Authors: Sawsan As-Sanie; Sara R Till; Erika L Mowers; Courtney S Lim; Bethany D Skinner; Laura Fritsch; Alex Tsodikov; Vanessa K Dalton; Daniel J Clauw; Chad M Brummett Journal: Obstet Gynecol Date: 2017-12 Impact factor: 7.661
Authors: Lekha S Hota; Hussein A Warda; Miriam J Haviland; Frances M Searle; Michele R Hacker Journal: Int Urogynecol J Date: 2017-09-09 Impact factor: 2.894